IO Biotech, Inc. (NASDAQ:IOBT – Get Free Report) was the recipient of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 200,900 shares, an increase of 17.0% from the November 15th total of 171,700 shares. Based on an average daily volume of 157,600 shares, […]
IO Biotech, Inc. (NASDAQ:IOBT – Get Free Report) saw a significant decrease in short interest in September. As of September 30th, there was short interest totalling 116,300 shares, a decrease of 57.2% from the September 15th total of 271,800 shares. Based on an average daily volume of 130,100 shares, the short-interest ratio is currently 0.9 […]
Piper Sandler initiated coverage on shares of IO Biotech (NASDAQ:IOBT – Free Report) in a research note issued to investors on Thursday, MarketBeat.com reports. The firm issued an overweight rating and a $10.00 price objective on the stock. IOBT has been the subject of several other research reports. Morgan Stanley lowered their price objective on […]
HC Wainwright reiterated their buy rating on shares of IO Biotech (NASDAQ:IOBT – Free Report) in a report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $8.00 price objective on the stock. Separately, Morgan Stanley cut their target price on shares of IO Biotech from $11.00 to $7.00 and set an overweight […]
IO Biotech, Inc. (NASDAQ:IOBT – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 447,500 shares, an increase of 5.7% from the June 30th total of 423,200 shares. Currently, 2.3% of the company’s shares are sold short. […]